These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

352 related articles for article (PubMed ID: 17551363)

  • 21. Treatment of ankylosing spondylitis with pamidronate: an open label study.
    Grover R; Shankar S; Aneja R; Marwaha V; Gupta R; Kumar A
    Ann Rheum Dis; 2006 May; 65(5):688-9. PubMed ID: 16611869
    [No Abstract]   [Full Text] [Related]  

  • 22. Transient efficacy of pulse pamidronate treatment in active spondylarthropathies: an open study of 35 cases.
    Toussirot E; Le Huédé G; Lohse A; Cédoz JP; Wendling D
    Clin Exp Rheumatol; 2006; 24(3):348. PubMed ID: 16870109
    [No Abstract]   [Full Text] [Related]  

  • 23. Late-onset ankylosing spondylitis and related spondylarthropathies: clinical and radiological characteristics and pharmacological treatment options.
    Toussirot E; Wendling D
    Drugs Aging; 2005; 22(6):451-69. PubMed ID: 15974637
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [The treatment of ankylosing spondylitis with auranofin (Ridaura)].
    Grasedyck K; Schattenkirchner M; Bandilla K
    Z Rheumatol; 1990; 49(2):98-9. PubMed ID: 2190436
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A comparative study of benoxaprofen and ketoprofen in ankylosing spondylitis.
    Charlot J; Villiaumey J
    Eur J Rheumatol Inflamm; 1982; 5(2):277-81. PubMed ID: 7044803
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pamidronate used to attenuate post-renal transplant bone loss is not associated with renal dysfunction.
    Lee S; Glicklich D; Coco M
    Nephrol Dial Transplant; 2004 Nov; 19(11):2870-3. PubMed ID: 15466880
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Intravenous high dose glucocorticoids in patients with ankylosing spondylitis].
    Rumiantseva OA; Bochkova AG; Liginova EIu; Kiseleva NM; Pushkova OV; Bunchuk NV
    Ter Arkh; 2006; 78(12):71-5. PubMed ID: 17294868
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Correlation between ossification and inflammation using a rat experimental model.
    Lussier A; de Medicis R
    J Rheumatol Suppl; 1983 Dec; 11():114-7. PubMed ID: 6422038
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Treatment of ankylosing spondylitis.
    Clegg DO
    J Rheumatol Suppl; 2006 Sep; 78():24-31. PubMed ID: 17042057
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A comparative study of benoxaprofen and indomethacin in ankylosing spondylitis.
    Bird HA; Rhind VM; Pickup ME; Wright V
    J Rheumatol Suppl; 1980; 6():139-42. PubMed ID: 6993670
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Ankylosing spondylitis. Comparative trial of two non-steroidal anti-inflammatory agents: pirprofen and ketoprofen].
    Renier JC; Fournier M; Loyau G; Roux H
    Nouv Presse Med; 1982 Aug; 11(33):2494-6. PubMed ID: 6752874
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Ribbing disease: radiographic and biochemical characterization, lack of response to pamidronate.
    Ziran N; Hill S; Wright ME; Kovacs J; Robey PG; Wientroub S; Collins MT
    Skeletal Radiol; 2002 Dec; 31(12):714-9. PubMed ID: 12483434
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Flexibilization of infliximab dose interval in the treatment of ankylosing spondylitis].
    Vinagre F; Santos MJ; Silva JC
    Acta Reumatol Port; 2007; 32(3):271-3. PubMed ID: 17940497
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A review of the literature on osteonecrosis of the jaw in patients with osteoporosis treated with oral bisphosphonates: prevalence, risk factors, and clinical characteristics.
    Pazianas M; Miller P; Blumentals WA; Bernal M; Kothawala P
    Clin Ther; 2007 Aug; 29(8):1548-58. PubMed ID: 17919538
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Piroxicam--a literature review of new results from laboratory and clinical studies.
    Ando GA; Lombardino JG
    Eur J Rheumatol Inflamm; 1983; 6(1):3-23. PubMed ID: 6345166
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical evaluation of novel bisphosphonate dosing regimens in osteoporosis: the role of comparative studies and implications for future studies.
    Cosman F; Borges JL; Curiel MD
    Clin Ther; 2007 Jun; 29(6):1116-27. PubMed ID: 17692726
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pharmacological treatment of ankylosing spondylitis: a systematic review.
    Boulos P; Dougados M; Macleod SM; Hunsche E
    Drugs; 2005; 65(15):2111-27. PubMed ID: 16225367
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Infliximab in severe active ankylosing spondylitis with spinal ankylosis.
    Cheung PP; Tymms KE; Wilson BJ; Shadbolt B; Brook AS; Dorai Raj AK; Khoo KB
    Intern Med J; 2008 Jun; 38(6):396-401. PubMed ID: 18336538
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Clinical evaluation of the preparation Donalgin in the treatment of rheumatoid arthritis and ankylosing spondylitis].
    Sadkiewicz S; Barwik-Schramm A; Grzywa M; Letkiewicz C; Piotrowska E; Procel Z; Reszkowska H; Wippel A; Woźniak M; Zmudzińska I
    Reumatologia; 1982; 20(1-2):75-80. PubMed ID: 6761815
    [No Abstract]   [Full Text] [Related]  

  • 40. Clinical application of D-penicillamine in ankylosing spondylitis: a 9-month study.
    Bernacka K; Tytman K; Sierakowski S
    Med Interne; 1989; 27(4):295-301. PubMed ID: 2694320
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.